

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 4.79827160 |
| 2 | aldehyde catabolic process (GO:0046185) | 3.84992465 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.78959573 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 3.78959573 |
| 5 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.71426559 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 3.69193067 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.69193067 |
| 8 | drug transmembrane transport (GO:0006855) | 3.58700730 |
| 9 | urate metabolic process (GO:0046415) | 3.45123208 |
| 10 | glyoxylate metabolic process (GO:0046487) | 3.43345223 |
| 11 | drug transport (GO:0015893) | 3.35085948 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.34966376 |
| 13 | cysteine metabolic process (GO:0006534) | 3.33437910 |
| 14 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.32356890 |
| 15 | valine metabolic process (GO:0006573) | 3.27170581 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 3.09012516 |
| 17 | ATP synthesis coupled proton transport (GO:0015986) | 3.09005209 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.09005209 |
| 19 | branched-chain amino acid metabolic process (GO:0009081) | 3.08038181 |
| 20 | cytidine deamination (GO:0009972) | 3.07661129 |
| 21 | cytidine metabolic process (GO:0046087) | 3.07661129 |
| 22 | cytidine catabolic process (GO:0006216) | 3.07661129 |
| 23 | respiratory electron transport chain (GO:0022904) | 3.05762162 |
| 24 | branched-chain amino acid catabolic process (GO:0009083) | 3.03422376 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.01389904 |
| 26 | electron transport chain (GO:0022900) | 2.99713042 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.90210661 |
| 28 | response to interferon-beta (GO:0035456) | 2.90078905 |
| 29 | glycoside metabolic process (GO:0016137) | 2.88418618 |
| 30 | endosome to pigment granule transport (GO:0043485) | 2.85743413 |
| 31 | endosome to melanosome transport (GO:0035646) | 2.85743413 |
| 32 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.84783539 |
| 33 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.84511978 |
| 34 | neutrophil activation (GO:0042119) | 2.83527125 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 2.83303034 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.82455293 |
| 37 | respiratory burst (GO:0045730) | 2.82291223 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.78774807 |
| 39 | organic cation transport (GO:0015695) | 2.77240914 |
| 40 | regulation of metalloenzyme activity (GO:0048552) | 2.77219925 |
| 41 | nucleotide transmembrane transport (GO:1901679) | 2.75233853 |
| 42 | amyloid precursor protein catabolic process (GO:0042987) | 2.74999443 |
| 43 | glutathione metabolic process (GO:0006749) | 2.72852345 |
| 44 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.67614763 |
| 45 | lysine metabolic process (GO:0006553) | 2.67569621 |
| 46 | lysine catabolic process (GO:0006554) | 2.67569621 |
| 47 | regulation of regulatory T cell differentiation (GO:0045589) | 2.67521864 |
| 48 | glucuronate metabolic process (GO:0019585) | 2.67287557 |
| 49 | uronic acid metabolic process (GO:0006063) | 2.67287557 |
| 50 | response to mercury ion (GO:0046689) | 2.66758366 |
| 51 | tricarboxylic acid metabolic process (GO:0072350) | 2.64390262 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 2.63375835 |
| 53 | DNA deamination (GO:0045006) | 2.62014483 |
| 54 | fatty acid beta-oxidation (GO:0006635) | 2.60733550 |
| 55 | microglial cell activation (GO:0001774) | 2.60668181 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.60189461 |
| 57 | glutathione derivative metabolic process (GO:1901685) | 2.59664359 |
| 58 | glutathione derivative biosynthetic process (GO:1901687) | 2.59664359 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.58445112 |
| 60 | GPI anchor biosynthetic process (GO:0006506) | 2.56881038 |
| 61 | granulocyte activation (GO:0036230) | 2.54641534 |
| 62 | hydrogen peroxide catabolic process (GO:0042744) | 2.54412650 |
| 63 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.54374153 |
| 64 | heme metabolic process (GO:0042168) | 2.54168486 |
| 65 | GPI anchor metabolic process (GO:0006505) | 2.54074916 |
| 66 | regulation of interleukin-8 secretion (GO:2000482) | 2.53749746 |
| 67 | short-chain fatty acid metabolic process (GO:0046459) | 2.53624424 |
| 68 | C-terminal protein lipidation (GO:0006501) | 2.53430154 |
| 69 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.53275420 |
| 70 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.53275420 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 2.52565065 |
| 72 | adenosine metabolic process (GO:0046085) | 2.52129743 |
| 73 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.51417351 |
| 74 | tryptophan metabolic process (GO:0006568) | 2.51074050 |
| 75 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.50703006 |
| 76 | cofactor catabolic process (GO:0051187) | 2.50607611 |
| 77 | respiratory chain complex IV assembly (GO:0008535) | 2.50544229 |
| 78 | positive regulation of mast cell degranulation (GO:0043306) | 2.50054169 |
| 79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.50054169 |
| 80 | T-helper 1 type immune response (GO:0042088) | 2.49205218 |
| 81 | lipid oxidation (GO:0034440) | 2.49057287 |
| 82 | fatty acid oxidation (GO:0019395) | 2.48925233 |
| 83 | reactive oxygen species biosynthetic process (GO:1903409) | 2.46739061 |
| 84 | tryptophan catabolic process (GO:0006569) | 2.46599532 |
| 85 | indole-containing compound catabolic process (GO:0042436) | 2.46599532 |
| 86 | indolalkylamine catabolic process (GO:0046218) | 2.46599532 |
| 87 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.46593933 |
| 88 | positive regulation of prostaglandin secretion (GO:0032308) | 2.46417202 |
| 89 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.45956643 |
| 90 | glutathione biosynthetic process (GO:0006750) | 2.45823003 |
| 91 | cellular glucuronidation (GO:0052695) | 2.45558476 |
| 92 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.45300398 |
| 93 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.44659552 |
| 94 | cytochrome complex assembly (GO:0017004) | 2.44184530 |
| 95 | protein complex biogenesis (GO:0070271) | 2.43700529 |
| 96 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.43565257 |
| 97 | hydrogen peroxide metabolic process (GO:0042743) | 2.42167427 |
| 98 | fatty acid catabolic process (GO:0009062) | 2.41079772 |
| 99 | toxin transport (GO:1901998) | 2.41064517 |
| 100 | ketone body metabolic process (GO:1902224) | 2.40788650 |
| 101 | dopamine transport (GO:0015872) | 2.40537095 |
| 102 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.40092440 |
| 103 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.38806844 |
| 104 | cellular ketone body metabolic process (GO:0046950) | 2.37932500 |
| 105 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.36676766 |
| 106 | mannosylation (GO:0097502) | 2.36557178 |
| 107 | aromatic amino acid family metabolic process (GO:0009072) | 2.36533910 |
| 108 | peptide catabolic process (GO:0043171) | 2.34254632 |
| 109 | protein neddylation (GO:0045116) | 2.33594921 |
| 110 | platelet dense granule organization (GO:0060155) | 2.33342457 |
| 111 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.32893741 |
| 112 | regulation of memory T cell differentiation (GO:0043380) | 2.32254087 |
| 113 | peptide metabolic process (GO:0006518) | 2.32088480 |
| 114 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.31772992 |
| 115 | NADH dehydrogenase complex assembly (GO:0010257) | 2.31772992 |
| 116 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.31772992 |
| 117 | xenobiotic catabolic process (GO:0042178) | 2.31343475 |
| 118 | ribosomal small subunit assembly (GO:0000028) | 2.30357461 |
| 119 | nucleoside diphosphate catabolic process (GO:0009134) | 2.30166283 |
| 120 | negative regulation of cell killing (GO:0031342) | 2.29778343 |
| 121 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.29778343 |
| 122 | negative regulation of acute inflammatory response (GO:0002674) | 2.29403136 |
| 123 | proton transport (GO:0015992) | 2.29320396 |
| 124 | fatty acid elongation (GO:0030497) | 2.28542571 |
| 125 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.27919593 |
| 126 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.27769489 |
| 127 | oxidative phosphorylation (GO:0006119) | 2.27513439 |
| 128 | hydrogen transport (GO:0006818) | 2.27034222 |
| 129 | regulation of mast cell activation (GO:0033003) | 2.26717276 |
| 130 | hydrogen ion transmembrane transport (GO:1902600) | 2.26690226 |
| 131 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.26222738 |
| 132 | response to nitrosative stress (GO:0051409) | 2.25988223 |
| 133 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.25776406 |
| 134 | sequestering of metal ion (GO:0051238) | 2.25651120 |
| 135 | heme biosynthetic process (GO:0006783) | 2.25263927 |
| 136 | cellular aldehyde metabolic process (GO:0006081) | 2.25176686 |
| 137 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.25046389 |
| 138 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.25004524 |
| 139 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.24367573 |
| 140 | proteasome assembly (GO:0043248) | 2.24061566 |
| 141 | negative regulation of complement activation (GO:0045916) | 2.22903424 |
| 142 | eosinophil chemotaxis (GO:0048245) | 2.22384988 |
| 143 | mast cell activation (GO:0045576) | 2.22382076 |
| 144 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.22327920 |
| 145 | response to thyroid hormone (GO:0097066) | 2.21640031 |
| 146 | aspartate family amino acid catabolic process (GO:0009068) | 2.20163203 |
| 147 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.20012704 |
| 148 | indolalkylamine metabolic process (GO:0006586) | 2.19855014 |
| 149 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.19804135 |
| 150 | cellular response to interferon-beta (GO:0035458) | 2.19536590 |
| 151 | cellular response to interleukin-15 (GO:0071350) | 2.19524828 |
| 152 | monocarboxylic acid catabolic process (GO:0072329) | 2.19242778 |
| 153 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.19174617 |
| 154 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.19174617 |
| 155 | carbohydrate derivative transport (GO:1901264) | 2.18261487 |
| 156 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.18239840 |
| 157 | secretory granule organization (GO:0033363) | 2.17070859 |
| 158 | axoneme assembly (GO:0035082) | 2.16496012 |
| 159 | C-terminal protein amino acid modification (GO:0018410) | 2.16100020 |
| 160 | cellular response to zinc ion (GO:0071294) | 2.14581596 |
| 161 | negative regulation of humoral immune response (GO:0002921) | 2.13140671 |
| 162 | B cell mediated immunity (GO:0019724) | 2.12585459 |
| 163 | vitamin biosynthetic process (GO:0009110) | 2.12322867 |
| 164 | S-adenosylmethionine metabolic process (GO:0046500) | 2.11596045 |
| 165 | leukotriene biosynthetic process (GO:0019370) | 2.10881716 |
| 166 | negative regulation of mast cell activation (GO:0033004) | 2.10532831 |
| 167 | fucose catabolic process (GO:0019317) | 2.09814663 |
| 168 | L-fucose metabolic process (GO:0042354) | 2.09814663 |
| 169 | L-fucose catabolic process (GO:0042355) | 2.09814663 |
| 170 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.08927786 |
| 171 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.08584257 |
| 172 | dendritic cell migration (GO:0036336) | 2.07263895 |
| 173 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.06749475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.42444843 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.95596015 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.55829923 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.27565079 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99855443 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.88940919 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.82083445 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.76071563 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.74943988 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.74551941 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.67647794 |
| 12 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.67320385 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.59293292 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.59002084 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.56228670 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.42703233 |
| 17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.36417138 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.33893171 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.30173423 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.19080356 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.19024340 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.17824682 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.09584200 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.04960199 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.99628207 |
| 26 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98266021 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94979190 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.94583357 |
| 29 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.93275307 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86427415 |
| 31 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.84010858 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.82578537 |
| 33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.80151363 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79619173 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79584595 |
| 36 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77939676 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77167617 |
| 38 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.76616674 |
| 39 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.71418069 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70708107 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69119447 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.68751691 |
| 43 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68727374 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68447267 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.67788236 |
| 46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.67726910 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66310796 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63025893 |
| 49 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62733135 |
| 50 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60747546 |
| 51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.60379585 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56461610 |
| 53 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.54680105 |
| 54 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53753741 |
| 55 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.52731665 |
| 56 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.51077660 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.50230009 |
| 58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.48013245 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.47683043 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.45029298 |
| 61 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.42805449 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42665587 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42416665 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42225989 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.41596190 |
| 66 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.41460501 |
| 67 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.40856766 |
| 68 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40231906 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39745782 |
| 70 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.36958622 |
| 71 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.36958622 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36504499 |
| 73 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.36212797 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35964680 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35527481 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34885773 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34744826 |
| 78 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.32288571 |
| 79 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.32288571 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.32012144 |
| 81 | MYB_26560356_Chip-Seq_TH2_Human | 1.31876948 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30550963 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29329731 |
| 84 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.28509433 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26534395 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26211666 |
| 87 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25982203 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24226048 |
| 89 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.21373225 |
| 90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.21337328 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20456151 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20332608 |
| 93 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.19869924 |
| 94 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.19409376 |
| 95 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.18589832 |
| 96 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.18233582 |
| 97 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.18070959 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16663439 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16648444 |
| 100 | EWS_26573619_Chip-Seq_HEK293_Human | 1.16591530 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16569430 |
| 102 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.16339952 |
| 103 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15089487 |
| 104 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13888716 |
| 105 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13559773 |
| 106 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13559274 |
| 107 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13423934 |
| 108 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11796223 |
| 109 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10736067 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09785463 |
| 111 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.09368986 |
| 112 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09316302 |
| 113 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08031298 |
| 114 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07253544 |
| 115 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07234055 |
| 116 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.07018404 |
| 117 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06936976 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06936976 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06160477 |
| 120 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06120813 |
| 121 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05549276 |
| 122 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.05068524 |
| 123 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03860641 |
| 124 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03699046 |
| 125 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03190995 |
| 126 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02773948 |
| 127 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.02411670 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99957821 |
| 129 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.98272273 |
| 130 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98016933 |
| 131 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97840298 |
| 132 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97696307 |
| 133 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97238008 |
| 134 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96948970 |
| 135 | AR_20517297_ChIP-Seq_VCAP_Human | 0.96639190 |
| 136 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.96379974 |
| 137 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96231231 |
| 138 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96110293 |
| 139 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96104566 |
| 140 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95913585 |
| 141 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95722723 |
| 142 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.95633249 |
| 143 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95577409 |
| 144 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95014394 |
| 145 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.95011656 |
| 146 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94598530 |
| 147 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94550192 |
| 148 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93704991 |
| 149 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93079503 |
| 150 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92241221 |
| 151 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90106846 |
| 152 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89099323 |
| 153 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88227898 |
| 154 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87932740 |
| 155 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.86904833 |
| 156 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.84295087 |
| 157 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83906508 |
| 158 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83410313 |
| 159 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83079463 |
| 160 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.83044735 |
| 161 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.82590848 |
| 162 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.81889506 |
| 163 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.81883383 |
| 164 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81633064 |
| 165 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81466501 |
| 166 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.78691309 |
| 167 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78453502 |
| 168 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.77697619 |
| 169 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77150308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.80702024 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.69903152 |
| 3 | MP0003195_calcinosis | 3.40728694 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.27601012 |
| 5 | MP0003186_abnormal_redox_activity | 3.16026554 |
| 6 | MP0004043_abnormal_pH_regulation | 3.07736696 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.88290426 |
| 8 | MP0005332_abnormal_amino_acid | 2.61347816 |
| 9 | MP0003724_increased_susceptibility_to | 2.58049242 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.52940823 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.51095258 |
| 12 | MP0005365_abnormal_bile_salt | 2.37446378 |
| 13 | MP0009785_altered_susceptibility_to | 2.33107338 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.32234803 |
| 15 | MP0005075_abnormal_melanosome_morpholog | 2.30239722 |
| 16 | MP0009643_abnormal_urine_homeostasis | 2.27467354 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 2.22094699 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.21589235 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.17594955 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.08404092 |
| 21 | MP0009840_abnormal_foam_cell | 2.04239776 |
| 22 | MP0005636_abnormal_mineral_homeostasis | 2.04180771 |
| 23 | MP0003436_decreased_susceptibility_to | 2.00279853 |
| 24 | MP0006036_abnormal_mitochondrial_physio | 1.97018344 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 1.96986132 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.82242274 |
| 27 | MP0000685_abnormal_immune_system | 1.78968310 |
| 28 | MP0002163_abnormal_gland_morphology | 1.77494803 |
| 29 | MP0002419_abnormal_innate_immunity | 1.76399003 |
| 30 | MP0005025_abnormal_response_to | 1.71819546 |
| 31 | MP0004147_increased_porphyrin_level | 1.71796412 |
| 32 | MP0006082_CNS_inflammation | 1.64615799 |
| 33 | MP0008469_abnormal_protein_level | 1.64329183 |
| 34 | MP0003011_delayed_dark_adaptation | 1.64002494 |
| 35 | MP0005083_abnormal_biliary_tract | 1.62638655 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.61581100 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60239629 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.59020547 |
| 39 | MP0001756_abnormal_urination | 1.57080896 |
| 40 | MP0005671_abnormal_response_to | 1.56311332 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.56270622 |
| 42 | MP0009764_decreased_sensitivity_to | 1.55699309 |
| 43 | MP0001764_abnormal_homeostasis | 1.54217252 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.51137354 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.50859421 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.48276066 |
| 47 | MP0005174_abnormal_tail_pigmentation | 1.45939070 |
| 48 | MP0001765_abnormal_ion_homeostasis | 1.45320696 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.45311852 |
| 50 | MP0001790_abnormal_immune_system | 1.41132640 |
| 51 | MP0005387_immune_system_phenotype | 1.41132640 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.40626608 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.39814308 |
| 54 | MP0003252_abnormal_bile_duct | 1.36313066 |
| 55 | MP0001853_heart_inflammation | 1.35138206 |
| 56 | MP0002136_abnormal_kidney_physiology | 1.34131289 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.29600500 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.29441382 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.29124216 |
| 60 | MP0000343_altered_response_to | 1.27884071 |
| 61 | MP0008872_abnormal_physiological_respon | 1.22956008 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.21628953 |
| 63 | MP0005408_hypopigmentation | 1.21595777 |
| 64 | MP0002723_abnormal_immune_serum | 1.20367171 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.18955089 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.18276862 |
| 67 | MP0006054_spinal_hemorrhage | 1.18089471 |
| 68 | MP0002118_abnormal_lipid_homeostasis | 1.17114877 |
| 69 | MP0000920_abnormal_myelination | 1.15365854 |
| 70 | MP0002095_abnormal_skin_pigmentation | 1.14846397 |
| 71 | MP0002452_abnormal_antigen_presenting | 1.12901571 |
| 72 | MP0005451_abnormal_body_composition | 1.12855697 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.12719704 |
| 74 | MP0000609_abnormal_liver_physiology | 1.04776113 |
| 75 | MP0002909_abnormal_adrenal_gland | 1.04579204 |
| 76 | MP0008260_abnormal_autophagy | 1.03337496 |
| 77 | MP0000372_irregular_coat_pigmentation | 1.03119785 |
| 78 | MP0003075_altered_response_to | 1.01317074 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 1.00613758 |
| 80 | MP0000716_abnormal_immune_system | 0.99631045 |
| 81 | MP0000689_abnormal_spleen_morphology | 0.98422506 |
| 82 | MP0005253_abnormal_eye_physiology | 0.97345535 |
| 83 | MP0009763_increased_sensitivity_to | 0.94518821 |
| 84 | MP0001819_abnormal_immune_cell | 0.94405657 |
| 85 | MP0002420_abnormal_adaptive_immunity | 0.93650007 |
| 86 | MP0010155_abnormal_intestine_physiology | 0.93364371 |
| 87 | MP0001800_abnormal_humoral_immune | 0.93248887 |
| 88 | MP0005410_abnormal_fertilization | 0.93238566 |
| 89 | MP0003646_muscle_fatigue | 0.93169625 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.91987477 |
| 91 | MP0010386_abnormal_urinary_bladder | 0.91934121 |
| 92 | MP0003763_abnormal_thymus_physiology | 0.91586207 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.87910824 |
| 94 | MP0002933_joint_inflammation | 0.87526712 |
| 95 | MP0004883_abnormal_blood_vessel | 0.87525477 |
| 96 | MP0000604_amyloidosis | 0.86934249 |
| 97 | MP0008877_abnormal_DNA_methylation | 0.86878464 |
| 98 | MP0001873_stomach_inflammation | 0.85829878 |
| 99 | MP0001542_abnormal_bone_strength | 0.85444209 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.85012919 |
| 101 | MP0004381_abnormal_hair_follicle | 0.84784972 |
| 102 | MP0009697_abnormal_copulation | 0.84490635 |
| 103 | MP0000427_abnormal_hair_cycle | 0.83842985 |
| 104 | MP0000465_gastrointestinal_hemorrhage | 0.83825987 |
| 105 | MP0005535_abnormal_body_temperature | 0.82165397 |
| 106 | MP0005645_abnormal_hypothalamus_physiol | 0.81297150 |
| 107 | MP0002693_abnormal_pancreas_physiology | 0.79482381 |
| 108 | MP0005164_abnormal_response_to | 0.79370849 |
| 109 | MP0002398_abnormal_bone_marrow | 0.79262037 |
| 110 | MP0003638_abnormal_response/metabolism_ | 0.79198481 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.78983398 |
| 112 | MP0005220_abnormal_exocrine_pancreas | 0.78905605 |
| 113 | MP0005310_abnormal_salivary_gland | 0.78710792 |
| 114 | MP0002006_tumorigenesis | 0.78068010 |
| 115 | MP0009333_abnormal_splenocyte_physiolog | 0.77392604 |
| 116 | MP0003866_abnormal_defecation | 0.76405316 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.75782943 |
| 118 | MP0004782_abnormal_surfactant_physiolog | 0.75612969 |
| 119 | MP0005166_decreased_susceptibility_to | 0.72883411 |
| 120 | MP0003690_abnormal_glial_cell | 0.72391072 |
| 121 | MP0002132_abnormal_respiratory_system | 0.72009532 |
| 122 | MP0002405_respiratory_system_inflammati | 0.71099136 |
| 123 | MP0005379_endocrine/exocrine_gland_phen | 0.70596815 |
| 124 | MP0000538_abnormal_urinary_bladder | 0.70252925 |
| 125 | MP0000598_abnormal_liver_morphology | 0.70184030 |
| 126 | MP0001986_abnormal_taste_sensitivity | 0.70160588 |
| 127 | MP0005670_abnormal_white_adipose | 0.69765244 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.68829955 |
| 129 | MP0002998_abnormal_bone_remodeling | 0.68321185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Generalized aminoaciduria (HP:0002909) | 4.15238408 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 3.96766851 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.80549511 |
| 4 | Stomatitis (HP:0010280) | 3.58916809 |
| 5 | Hepatic necrosis (HP:0002605) | 3.39245082 |
| 6 | Acute encephalopathy (HP:0006846) | 3.26975111 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.17475177 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.16895977 |
| 9 | Abnormality of urine glucose concentration (HP:0011016) | 3.13729345 |
| 10 | Glycosuria (HP:0003076) | 3.13729345 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.07550540 |
| 12 | Hypokalemic alkalosis (HP:0001949) | 3.06535518 |
| 13 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.06365484 |
| 14 | Dicarboxylic aciduria (HP:0003215) | 3.06365484 |
| 15 | Proximal tubulopathy (HP:0000114) | 3.04882005 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.04829027 |
| 17 | Mitochondrial inheritance (HP:0001427) | 2.99753460 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.98713264 |
| 19 | Gout (HP:0001997) | 2.90463850 |
| 20 | Cerebral edema (HP:0002181) | 2.90223053 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.87707067 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.87707067 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 2.86043549 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.86043549 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.86043549 |
| 26 | Hypoglycemic coma (HP:0001325) | 2.84357983 |
| 27 | Metabolic alkalosis (HP:0200114) | 2.77022113 |
| 28 | Methylmalonic acidemia (HP:0002912) | 2.74651778 |
| 29 | Hypomagnesemia (HP:0002917) | 2.70421012 |
| 30 | Hyperactive renin-angiotensin system (HP:0000841) | 2.70061724 |
| 31 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.69907215 |
| 32 | Abnormality of magnesium homeostasis (HP:0004921) | 2.69781517 |
| 33 | Renal Fanconi syndrome (HP:0001994) | 2.63234887 |
| 34 | Increased CSF lactate (HP:0002490) | 2.63030275 |
| 35 | Abnormality of macrophages (HP:0004311) | 2.58821664 |
| 36 | Hyperphosphaturia (HP:0003109) | 2.51375086 |
| 37 | Abnormality of renal resorption (HP:0011038) | 2.50168576 |
| 38 | Alkalosis (HP:0001948) | 2.49859488 |
| 39 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49847200 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.49564943 |
| 41 | Pancreatic cysts (HP:0001737) | 2.49559909 |
| 42 | Lactic acidosis (HP:0003128) | 2.48049471 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.48040468 |
| 44 | Axonal loss (HP:0003447) | 2.47085287 |
| 45 | Ketoacidosis (HP:0001993) | 2.46854032 |
| 46 | Progressive macrocephaly (HP:0004481) | 2.46435919 |
| 47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.45404801 |
| 48 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.44747092 |
| 49 | Hypoplasia of the fovea (HP:0007750) | 2.44747092 |
| 50 | Increased circulating renin level (HP:0000848) | 2.43229730 |
| 51 | Hyperglycinuria (HP:0003108) | 2.42349836 |
| 52 | Abolished electroretinogram (ERG) (HP:0000550) | 2.41428298 |
| 53 | Recurrent abscess formation (HP:0002722) | 2.40816245 |
| 54 | Recurrent bacterial skin infections (HP:0005406) | 2.39273274 |
| 55 | Ketosis (HP:0001946) | 2.38285954 |
| 56 | Lethargy (HP:0001254) | 2.38042166 |
| 57 | IgG deficiency (HP:0004315) | 2.35872734 |
| 58 | Polyuria (HP:0000103) | 2.35652532 |
| 59 | Abnormality of chloride homeostasis (HP:0011422) | 2.35571272 |
| 60 | Abnormal urine output (HP:0012590) | 2.34480175 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.34298473 |
| 62 | Abnormality of T cell number (HP:0011839) | 2.34193537 |
| 63 | Abnormality of renal excretion (HP:0011036) | 2.32994878 |
| 64 | Myositis (HP:0100614) | 2.31740123 |
| 65 | T lymphocytopenia (HP:0005403) | 2.31694009 |
| 66 | Thyroiditis (HP:0100646) | 2.30938375 |
| 67 | Lipid accumulation in hepatocytes (HP:0006561) | 2.30562180 |
| 68 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.29587052 |
| 69 | Congenital, generalized hypertrichosis (HP:0004540) | 2.28648335 |
| 70 | Hypoproteinemia (HP:0003075) | 2.25961477 |
| 71 | Hypothermia (HP:0002045) | 2.24655474 |
| 72 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.24153841 |
| 73 | Abnormality of the fovea (HP:0000493) | 2.23182608 |
| 74 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.22770175 |
| 75 | Nausea (HP:0002018) | 2.22322059 |
| 76 | Vomiting (HP:0002013) | 2.22272234 |
| 77 | Congenital stationary night blindness (HP:0007642) | 2.21780253 |
| 78 | Congenital sensorineural hearing impairment (HP:0008527) | 2.21639618 |
| 79 | Intrahepatic cholestasis (HP:0001406) | 2.20896813 |
| 80 | Microvesicular hepatic steatosis (HP:0001414) | 2.20054355 |
| 81 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.18980436 |
| 82 | Optic neuritis (HP:0100653) | 2.18484831 |
| 83 | Retrobulbar optic neuritis (HP:0100654) | 2.18484831 |
| 84 | Increased hepatocellular lipid droplets (HP:0006565) | 2.18191313 |
| 85 | 3-Methylglutaconic aciduria (HP:0003535) | 2.17884594 |
| 86 | Hyperammonemia (HP:0001987) | 2.17805440 |
| 87 | Petechiae (HP:0000967) | 2.17170489 |
| 88 | Abnormality of the renal cortex (HP:0011035) | 2.17166703 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16842731 |
| 90 | True hermaphroditism (HP:0010459) | 2.16695716 |
| 91 | Xanthomatosis (HP:0000991) | 2.16689599 |
| 92 | Metabolic acidosis (HP:0001942) | 2.15515419 |
| 93 | Methylmalonic aciduria (HP:0012120) | 2.14891406 |
| 94 | Abnormal urine phosphate concentration (HP:0012599) | 2.13810333 |
| 95 | Renal cortical cysts (HP:0000803) | 2.12714243 |
| 96 | Abnormality of glycine metabolism (HP:0010895) | 2.12548966 |
| 97 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.12548966 |
| 98 | Abnormality of vitamin B metabolism (HP:0004340) | 2.11696269 |
| 99 | Pancreatic fibrosis (HP:0100732) | 2.11474494 |
| 100 | Abnormality of midbrain morphology (HP:0002418) | 2.09689814 |
| 101 | Molar tooth sign on MRI (HP:0002419) | 2.09689814 |
| 102 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.09049140 |
| 103 | Vascular calcification (HP:0004934) | 2.08896217 |
| 104 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07094906 |
| 105 | Abnormality of the prostate (HP:0008775) | 2.06959777 |
| 106 | Orchitis (HP:0100796) | 2.06779619 |
| 107 | Respiratory failure (HP:0002878) | 2.06115903 |
| 108 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.06081756 |
| 109 | Decreased central vision (HP:0007663) | 2.04210610 |
| 110 | Reduced antithrombin III activity (HP:0001976) | 2.03772831 |
| 111 | Large for gestational age (HP:0001520) | 2.00117977 |
| 112 | Exertional dyspnea (HP:0002875) | 1.98954614 |
| 113 | Renal tubular dysfunction (HP:0000124) | 1.98469422 |
| 114 | Recurrent fungal infections (HP:0002841) | 1.98131963 |
| 115 | Hyperuricemia (HP:0002149) | 1.97450233 |
| 116 | Increased purine levels (HP:0004368) | 1.97450233 |
| 117 | Medial flaring of the eyebrow (HP:0010747) | 1.97141888 |
| 118 | Pulmonary infiltrates (HP:0002113) | 1.96940343 |
| 119 | Abnormality of renin-angiotensin system (HP:0000847) | 1.96688322 |
| 120 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.96644078 |
| 121 | Spastic paraparesis (HP:0002313) | 1.96474007 |
| 122 | Attenuation of retinal blood vessels (HP:0007843) | 1.96199689 |
| 123 | Albinism (HP:0001022) | 1.96188141 |
| 124 | Exercise intolerance (HP:0003546) | 1.95724832 |
| 125 | Beaking of vertebral bodies (HP:0004568) | 1.95437118 |
| 126 | Abnormal drinking behavior (HP:0030082) | 1.95363239 |
| 127 | Polydipsia (HP:0001959) | 1.95363239 |
| 128 | Hyperaldosteronism (HP:0000859) | 1.94820691 |
| 129 | Abnormality of T cells (HP:0002843) | 1.93782466 |
| 130 | Opisthotonus (HP:0002179) | 1.93767602 |
| 131 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.93567748 |
| 132 | Absent/shortened dynein arms (HP:0200106) | 1.93567748 |
| 133 | Increased serum lactate (HP:0002151) | 1.92760807 |
| 134 | Progressive neurologic deterioration (HP:0002344) | 1.92565387 |
| 135 | Tetany (HP:0001281) | 1.92138931 |
| 136 | Recurrent skin infections (HP:0001581) | 1.91679603 |
| 137 | Abnormal tarsal ossification (HP:0008369) | 1.91376952 |
| 138 | Abnormality of nucleobase metabolism (HP:0010932) | 1.90773561 |
| 139 | Abnormality of B cell number (HP:0010975) | 1.89257425 |
| 140 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88863571 |
| 141 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88863571 |
| 142 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88863571 |
| 143 | Abnormal protein glycosylation (HP:0012346) | 1.87998307 |
| 144 | Abnormal glycosylation (HP:0012345) | 1.87998307 |
| 145 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.87998307 |
| 146 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87998307 |
| 147 | Mucopolysacchariduria (HP:0008155) | 1.87968654 |
| 148 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87968654 |
| 149 | Renal salt wasting (HP:0000127) | 1.87164151 |
| 150 | Recurrent bronchitis (HP:0002837) | 1.86976890 |
| 151 | Type I transferrin isoform profile (HP:0003642) | 1.86881813 |
| 152 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.82722090 |
| 153 | Recurrent cutaneous fungal infections (HP:0011370) | 1.82722090 |
| 154 | Conjunctival hamartoma (HP:0100780) | 1.82127755 |
| 155 | Obstructive lung disease (HP:0006536) | 1.78558764 |
| 156 | Chronic obstructive pulmonary disease (HP:0006510) | 1.78558764 |
| 157 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.78272615 |
| 158 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.77995687 |
| 159 | Hemoptysis (HP:0002105) | 1.77425823 |
| 160 | Eczematoid dermatitis (HP:0000976) | 1.75453676 |
| 161 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.74747438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.37386568 |
| 2 | BCKDK | 3.30423878 |
| 3 | WNK4 | 3.01046600 |
| 4 | STK16 | 2.91544979 |
| 5 | PIM2 | 2.90772801 |
| 6 | PBK | 2.66292156 |
| 7 | OXSR1 | 2.56113492 |
| 8 | MST4 | 2.46808816 |
| 9 | IRAK3 | 2.45746304 |
| 10 | NUAK1 | 2.39487219 |
| 11 | STK39 | 2.37830560 |
| 12 | MAP4K2 | 2.31725645 |
| 13 | EIF2AK3 | 2.27795744 |
| 14 | ERN1 | 2.07599994 |
| 15 | ARAF | 2.03938127 |
| 16 | GRK1 | 1.99445834 |
| 17 | MAP3K14 | 1.94453244 |
| 18 | IRAK4 | 1.94414526 |
| 19 | TBK1 | 1.91745899 |
| 20 | EIF2AK1 | 1.89857563 |
| 21 | WNK3 | 1.69989370 |
| 22 | MYLK | 1.69947133 |
| 23 | MUSK | 1.66459969 |
| 24 | TEC | 1.57992901 |
| 25 | IKBKE | 1.41009296 |
| 26 | PINK1 | 1.37287137 |
| 27 | VRK2 | 1.34062187 |
| 28 | GRK6 | 1.32544819 |
| 29 | EPHB1 | 1.28905557 |
| 30 | IKBKB | 1.28136476 |
| 31 | FES | 1.28126702 |
| 32 | KDR | 1.27114539 |
| 33 | KIT | 1.25000319 |
| 34 | ERBB3 | 1.22692112 |
| 35 | BMPR1B | 1.22539208 |
| 36 | ABL2 | 1.22074874 |
| 37 | MAP3K3 | 1.21601074 |
| 38 | MAP3K12 | 1.20186424 |
| 39 | TYK2 | 1.19903931 |
| 40 | TLK1 | 1.16831785 |
| 41 | INSRR | 1.11950069 |
| 42 | MAPKAPK3 | 1.10976529 |
| 43 | NME1 | 1.08503791 |
| 44 | TESK2 | 1.07761912 |
| 45 | PIK3CG | 1.07623172 |
| 46 | FLT3 | 1.07611856 |
| 47 | ITK | 1.07150795 |
| 48 | CSK | 1.04872881 |
| 49 | BLK | 1.04557946 |
| 50 | IRAK1 | 1.02172068 |
| 51 | MAP4K1 | 1.01765292 |
| 52 | ADRBK2 | 1.01761602 |
| 53 | BTK | 1.01026818 |
| 54 | TIE1 | 0.99924454 |
| 55 | PTK2B | 0.99608591 |
| 56 | JAK3 | 0.99380332 |
| 57 | MAPKAPK5 | 0.99125237 |
| 58 | TESK1 | 0.98304438 |
| 59 | TAOK3 | 0.97358319 |
| 60 | MAP3K11 | 0.97304345 |
| 61 | FER | 0.97118917 |
| 62 | MAPK15 | 0.94036817 |
| 63 | TNK2 | 0.91452392 |
| 64 | MST1R | 0.88750459 |
| 65 | ZAP70 | 0.88467135 |
| 66 | BUB1 | 0.86427510 |
| 67 | MET | 0.86243315 |
| 68 | MAP2K3 | 0.85917324 |
| 69 | CAMKK2 | 0.84653916 |
| 70 | ADRBK1 | 0.84218587 |
| 71 | TXK | 0.79529386 |
| 72 | TGFBR2 | 0.79169185 |
| 73 | PDK2 | 0.77443386 |
| 74 | IRAK2 | 0.77279732 |
| 75 | MAP2K6 | 0.77202211 |
| 76 | PAK3 | 0.76241299 |
| 77 | LIMK1 | 0.75782370 |
| 78 | TRPM7 | 0.74701915 |
| 79 | PRKG2 | 0.73613295 |
| 80 | NEK9 | 0.72886911 |
| 81 | RIPK4 | 0.71201390 |
| 82 | CSF1R | 0.70293771 |
| 83 | CDK19 | 0.69286245 |
| 84 | LRRK2 | 0.66378392 |
| 85 | GRK7 | 0.66359631 |
| 86 | JAK1 | 0.66093503 |
| 87 | BMPR2 | 0.66067882 |
| 88 | BRAF | 0.66058647 |
| 89 | MARK3 | 0.65711503 |
| 90 | TRIM28 | 0.65126047 |
| 91 | BRSK2 | 0.65099973 |
| 92 | LYN | 0.64757832 |
| 93 | GRK5 | 0.64414589 |
| 94 | STK24 | 0.64382894 |
| 95 | PRKCD | 0.62845769 |
| 96 | NEK1 | 0.61178353 |
| 97 | SYK | 0.60617496 |
| 98 | DAPK2 | 0.60373445 |
| 99 | ZAK | 0.59835221 |
| 100 | FRK | 0.57435401 |
| 101 | ABL1 | 0.56780509 |
| 102 | VRK1 | 0.56378887 |
| 103 | PRKCI | 0.56073922 |
| 104 | LMTK2 | 0.54721895 |
| 105 | STK10 | 0.53803161 |
| 106 | CAMK2G | 0.53734019 |
| 107 | PIM1 | 0.52272547 |
| 108 | IGF1R | 0.51944769 |
| 109 | STK38L | 0.51576257 |
| 110 | CDK8 | 0.50888466 |
| 111 | HCK | 0.50539855 |
| 112 | PLK2 | 0.50023473 |
| 113 | MATK | 0.49520837 |
| 114 | PHKG1 | 0.48667225 |
| 115 | PHKG2 | 0.48667225 |
| 116 | FGR | 0.47936853 |
| 117 | ILK | 0.47585348 |
| 118 | DAPK1 | 0.47421281 |
| 119 | TGFBR1 | 0.46614869 |
| 120 | EIF2AK2 | 0.45308155 |
| 121 | CSNK1G2 | 0.44675691 |
| 122 | DAPK3 | 0.44660701 |
| 123 | NEK6 | 0.44408283 |
| 124 | MAP2K2 | 0.43350704 |
| 125 | CSNK1G3 | 0.41430082 |
| 126 | LCK | 0.41024323 |
| 127 | PRKCQ | 0.40054998 |
| 128 | CAMK2D | 0.39785577 |
| 129 | RPS6KB2 | 0.39692641 |
| 130 | ACVR1B | 0.37920876 |
| 131 | PIK3CA | 0.36253680 |
| 132 | MAP3K1 | 0.34267066 |
| 133 | RPS6KA5 | 0.33964462 |
| 134 | MOS | 0.33588543 |
| 135 | TNIK | 0.33114532 |
| 136 | PRKCE | 0.32392760 |
| 137 | MAPKAPK2 | 0.31230230 |
| 138 | NLK | 0.30939527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.15005401 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.92034172 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.66864166 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.43359294 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.42439139 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39184147 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26106267 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.17539281 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.15184410 |
| 10 | Peroxisome_Homo sapiens_hsa04146 | 2.09790591 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.08041961 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 1.99723058 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.96492678 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87670715 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.80782395 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77642776 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.74505344 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.67701389 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.67079691 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.65458809 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64884856 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64350069 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.63659362 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.63237831 |
| 25 | Ribosome_Homo sapiens_hsa03010 | 1.61381719 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.59375661 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58916186 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55600047 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.55385617 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.55276767 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50651744 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.48826378 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48618856 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.44570146 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.44374537 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.43018674 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42688259 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39458848 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33465837 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.33395246 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.32416362 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31951437 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30624575 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30288836 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.19738952 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19558278 |
| 47 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19101262 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.14264756 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12698664 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12698177 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10911410 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 1.10783187 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09327280 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09108730 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08798120 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08115334 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04884146 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04046212 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02129172 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.00153648 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99420222 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.98529248 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97622140 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96949167 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96755134 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96584315 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95934742 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94987069 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93079302 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.92159054 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91116353 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90828656 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.89915037 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89078186 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88768994 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.88464726 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85806195 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85559028 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84793962 |
| 80 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84266288 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81716979 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80181871 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.80064801 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74623827 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74606768 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74521331 |
| 87 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73810113 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73138187 |
| 89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73118361 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.72745171 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72297352 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.72190946 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.71726928 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71110325 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70865531 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70845989 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | 0.70585015 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69184426 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67300906 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.66340960 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66182867 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65552307 |
| 103 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63280543 |
| 104 | Homologous recombination_Homo sapiens_hsa03440 | 0.61412210 |
| 105 | Malaria_Homo sapiens_hsa05144 | 0.60685897 |
| 106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60377101 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59217341 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58945874 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58471137 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58009382 |
| 111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56054698 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55608031 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54610446 |
| 114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53366283 |
| 115 | RNA degradation_Homo sapiens_hsa03018 | 0.52696342 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.51383088 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51376067 |
| 118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50090609 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49245690 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.49087149 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.48434441 |
| 122 | RNA polymerase_Homo sapiens_hsa03020 | 0.48169300 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.47338209 |
| 124 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47329155 |
| 125 | Measles_Homo sapiens_hsa05162 | 0.45891885 |
| 126 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44617619 |
| 127 | Asthma_Homo sapiens_hsa05310 | 0.44481924 |
| 128 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42142488 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37380376 |
| 130 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.35775979 |
| 131 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35559330 |

